You are here

AstraZeneca

AstraZeneca's Faslodex Gets FDA Nod for Use With Verzenio

Yahoo/Zacks.com

Thu, 11/16/17 - 11:13 am

AstraZeneca, Merck, Clovis and Tesaro, all vying for share, may all win on faster PARP growth

Fierce Pharma

Wed, 11/15/17 - 08:51 pm

Clovis Oncology

PARP inhibitors

AstraZeneca’s respiratory group scores FDA OK for a blockbuster severe asthma drug

Endpoints

Wed, 11/15/17 - 08:38 am

Can AstraZeneca afford its fervent commitment to paying a high dividend?

Fierce Pharma

Fri, 11/10/17 - 10:19 pm

AstraZeneca executives try to shift I-O focus with China, Brilinta wins

Fierce Pharma

Fri, 11/10/17 - 09:35 am

immuno-oncology

AstraZeneca Stock Gains as Crestor Sales Decline Slows

TheStreet.com

Thu, 11/9/17 - 05:59 pm

AstraZeneca inks a cardio drug development pact with mRNA specialist Moderna

Endpoints

Wed, 11/1/17 - 09:53 am

drug development

Moderna Therapeutics

AstraZeneca asthma drug tralokinumab disappoints again

Yahoo/Reuters

Wed, 11/1/17 - 09:37 am

AstraZeneca wins US approval for lymphoma drug

Yahoo/AP

Tue, 10/31/17 - 09:24 pm

mantle cell lymphoma

AstraZeneca plans new pivotal lung cancer trial with Incyte

Yahoo/Reuters

Tue, 10/31/17 - 10:04 am

clinical trials

AstraZeneca hands Mereo rights to lung drug

BioPharma Dive

Mon, 10/30/17 - 11:23 pm

Mereo BioPharma

What to expect from the rest of pharma's earnings

BioPharma Dive

Mon, 10/30/17 - 09:52 am

AstraZeneca 'all in' on severe asthma launch for late-to-the-party benralizumab

Fierce Pharma

Wed, 10/25/17 - 10:06 am

Eyeing an IPO, ADC Therapeutics fuels pivotal cancer trials with a $200M mega-round backed by AstraZeneca

Endpoints

Mon, 10/23/17 - 10:08 pm

ADC Therapeutics

antibody-drug conjugate

FDA clears AstraZeneca’s once-weekly Type II diabetes drug-device combo

Drug Delivery Business News

Mon, 10/23/17 - 10:01 am

drug-device combos

AstraZeneca EVP: Brexit is hindering our hiring

Fierce Biotech

Fri, 10/20/17 - 09:05 am

AstraZeneca's Acerta faked cancer drug data, company admits

Fierce Biotech

Mon, 10/16/17 - 12:56 pm

What's Behind AstraZeneca's September Rebound?

Motley Fool

Sun, 10/8/17 - 11:21 am

AstraZeneca, Tesaro and Clovis need to slash the cost of PARP meds, watchdog says

Fierce Pharma

Mon, 10/2/17 - 10:10 pm

Clovis Oncology

PARP inhibitors

Drugs firm AstraZeneca wants three-year Brexit transition

Yahoo/Reuters

Mon, 10/2/17 - 11:00 am

Pages